Brief: Newbury Pharmaceuticals Q2 Net Revenue Up At Sek 3.1 Mln
April 10 (Reuters) - Newbury Pharmaceuticals AB
NEWBRY.ST :
* Q2 NET REVENUE SEK 3.1 MILLION VERSUS SEK 1.5 MILLION YEAR
AGO
* Q2 EBITDA LOSS SEK 4.1 MILLION VERSUS LOSS SEK 4.6 MILLION
YEAR
AGO
Source text for Eikon: ID:nMFN6JSrrl
Further company coverage: NEWBRY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln